Reviews Optiray Injection


No reviews yet.

Optiray Injection Drug Description
Optiray™ 350
(ioversol) Injection 74%
Optiray™ 320
(ioversol) Injection 68%
Optiray™ 300
(ioversol) Injection 64%
Optiray™ 240
(ioversol) Injection 51%
Optiray™ 160
(ioversol) Injection 34%

WARNING
NOT FOR INTRATHECAL USE

DRUG DESCRIPTION



What are the possible side effects of ioversol (Optiray 160, Optiray 240, Optiray 300, Optiray 320, Optiray 350)?

Some of the side effects of ioversol can occur up to 24 hours after you have received the medication.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

urinating less than usual or not at all;
severe muscle pain or weakness;
...
Read All Potential Side Effects for Optiray Injection »




OPTIRAY (ioversol injection) formulations are sterile, nonpyrogenic, aqueous
solutions intended for intravascular administration as diagnostic radiopaque
media. Ioversol is designated chemically as N,N'-Bis (2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)
-glycolamido] -2,4,6-triiodoisophthalamide and has the following structural
formula:








The molecular weight of ioversol is 807.11 and the organically bound iodine content is 47.2%. Ioversol is nonionic and does not dissociate in solution.
Each milliliter of OPTIRAY 350 (ioversol injection 74%) contains 741 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 350 provides 35% (350 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 320 (ioversol injection 68%) contains 678 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 320 provides 32% (320 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 300 (ioversol injection 64%) contains 636 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 300 provides 30% (300 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 240 (ioversol injection 51%) contains 509 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 240 provides 24% (240 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 160 (ioversol injection 34%) contains 339 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 160 provides 16% (160 mg/mL) organically bound iodine.
The pH of the OPTIRAY formulations has been adjusted to 6.0 to 7.4 with hydrochloric acid or sodium hydroxide. All solutions are sterilized by autoclaving and contain no preservatives. Unused portions should be discarded. OPTIRAY solutions are sensitive to light and therefore should be protected from exposure.
Some physical and chemical properties of these formulations are listed below:



 
OPTIRAY
160
OPTIRAY
240
OPTIRAY
300
OPTIRAY
320
OPTIRAY
350


Ioversol content (mg/mL)
339
509
636
678
741


Iodine content (mg I/mL)
160
240
300
320
350


Osmolality (mOsm/kg water)
355
502
651
702
792


Viscosity (cps)


at 25°C
2.7
4.6
8.2
9.9
14.3


at 37°C
1.9
3.0
5.5
5.8
9.0


Specific Gravity at 37°C
1.188
1.281
1.352
1.371
1.405



The OPTIRAY formulations are clear, colorless to pale yellow solutions containing
no undissolved solids. Crystallization does not occur at room temperature. The
products are supplied in containers from which the air has been displaced by
nitrogen. OPTIRAY solutions have osmolalities 1.2 to 2.8 times that of plasma
(285 mOsm/kg water) as shown in the above table and are hypertonic under conditions
of use.Last reviewed on RxList: 6/18/2008




Optiray Injection Drug Description
Optiray™ 350
(ioversol) Injection 74%
Optiray™ 320
(ioversol) Injection 68%
Optiray™ 300
(ioversol) Injection 64%
Optiray™ 240
(ioversol) Injection 51%
Optiray™ 160
(ioversol) Injection 34%

WARNING
NOT FOR INTRATHECAL USE

DRUG DESCRIPTION



What are the possible side effects of ioversol (Optiray 160, Optiray 240, Optiray 300, Optiray 320, Optiray 350)?

Some of the side effects of ioversol can occur up to 24 hours after you have received the medication.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

urinating less than usual or not at all;
severe muscle pain or weakness;
...
Read All Potential Side Effects for Optiray Injection »




OPTIRAY (ioversol injection) formulations are sterile, nonpyrogenic, aqueous
solutions intended for intravascular administration as diagnostic radiopaque
media. Ioversol is designated chemically as N,N'-Bis (2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)
-glycolamido] -2,4,6-triiodoisophthalamide and has the following structural
formula:








The molecular weight of ioversol is 807.11 and the organically bound iodine content is 47.2%. Ioversol is nonionic and does not dissociate in solution.
Each milliliter of OPTIRAY 350 (ioversol injection 74%) contains 741 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 350 provides 35% (350 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 320 (ioversol injection 68%) contains 678 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 320 provides 32% (320 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 300 (ioversol injection 64%) contains 636 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 300 provides 30% (300 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 240 (ioversol injection 51%) contains 509 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 240 provides 24% (240 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 160 (ioversol injection 34%) contains 339 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 160 provides 16% (160 mg/mL) organically bound iodine.
The pH of the OPTIRAY formulations has been adjusted to 6.0 to 7.4 with hydrochloric acid or sodium hydroxide. All solutions are sterilized by autoclaving and contain no preservatives. Unused portions should be discarded. OPTIRAY solutions are sensitive to light and therefore should be protected from exposure.
Some physical and chemical properties of these formulations are listed below:



 
OPTIRAY
160
OPTIRAY
240
OPTIRAY
300
OPTIRAY
320
OPTIRAY
350


Ioversol content (mg/mL)
339
509
636
678
741


Iodine content (mg I/mL)
160
240
300
320
350


Osmolality (mOsm/kg water)
355
502
651
702
792


Viscosity (cps)


at 25°C
2.7
4.6
8.2
9.9
14.3


at 37°C
1.9
3.0
5.5
5.8
9.0


Specific Gravity at 37°C
1.188
1.281
1.352
1.371
1.405



The OPTIRAY formulations are clear, colorless to pale yellow solutions containing
no undissolved solids. Crystallization does not occur at room temperature. The
products are supplied in containers from which the air has been displaced by
nitrogen. OPTIRAY solutions have osmolalities 1.2 to 2.8 times that of plasma
(285 mOsm/kg water) as shown in the above table and are hypertonic under conditions
of use.Last reviewed on RxList: 6/18/2008




Optiray Injection Drug Description
Optiray™ 350
(ioversol) Injection 74%
Optiray™ 320
(ioversol) Injection 68%
Optiray™ 300
(ioversol) Injection 64%
Optiray™ 240
(ioversol) Injection 51%
Optiray™ 160
(ioversol) Injection 34%

WARNING
NOT FOR INTRATHECAL USE

DRUG DESCRIPTION



What are the possible side effects of ioversol (Optiray 160, Optiray 240, Optiray 300, Optiray 320, Optiray 350)?

Some of the side effects of ioversol can occur up to 24 hours after you have received the medication.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

urinating less than usual or not at all;
severe muscle pain or weakness;
...
Read All Potential Side Effects for Optiray Injection »




OPTIRAY (ioversol injection) formulations are sterile, nonpyrogenic, aqueous
solutions intended for intravascular administration as diagnostic radiopaque
media. Ioversol is designated chemically as N,N'-Bis (2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)
-glycolamido] -2,4,6-triiodoisophthalamide and has the following structural
formula:








The molecular weight of ioversol is 807.11 and the organically bound iodine content is 47.2%. Ioversol is nonionic and does not dissociate in solution.
Each milliliter of OPTIRAY 350 (ioversol injection 74%) contains 741 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 350 provides 35% (350 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 320 (ioversol injection 68%) contains 678 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 320 provides 32% (320 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 300 (ioversol injection 64%) contains 636 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 300 provides 30% (300 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 240 (ioversol injection 51%) contains 509 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 240 provides 24% (240 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 160 (ioversol injection 34%) contains 339 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 160 provides 16% (160 mg/mL) organically bound iodine.
The pH of the OPTIRAY formulations has been adjusted to 6.0 to 7.4 with hydrochloric acid or sodium hydroxide. All solutions are sterilized by autoclaving and contain no preservatives. Unused portions should be discarded. OPTIRAY solutions are sensitive to light and therefore should be protected from exposure.
Some physical and chemical properties of these formulations are listed below:



 
OPTIRAY
160
OPTIRAY
240
OPTIRAY
300
OPTIRAY
320
OPTIRAY
350


Ioversol content (mg/mL)
339
509
636
678
741


Iodine content (mg I/mL)
160
240
300
320
350


Osmolality (mOsm/kg water)
355
502
651
702
792


Viscosity (cps)


at 25°C
2.7
4.6
8.2
9.9
14.3


at 37°C
1.9
3.0
5.5
5.8
9.0


Specific Gravity at 37°C
1.188
1.281
1.352
1.371
1.405



The OPTIRAY formulations are clear, colorless to pale yellow solutions containing
no undissolved solids. Crystallization does not occur at room temperature. The
products are supplied in containers from which the air has been displaced by
nitrogen. OPTIRAY solutions have osmolalities 1.2 to 2.8 times that of plasma
(285 mOsm/kg water) as shown in the above table and are hypertonic under conditions
of use.Last reviewed on RxList: 6/18/2008




Optiray Injection Drug Description
Optiray™ 350
(ioversol) Injection 74%
Optiray™ 320
(ioversol) Injection 68%
Optiray™ 300
(ioversol) Injection 64%
Optiray™ 240
(ioversol) Injection 51%
Optiray™ 160
(ioversol) Injection 34%

WARNING
NOT FOR INTRATHECAL USE

DRUG DESCRIPTION



What are the possible side effects of ioversol (Optiray 160, Optiray 240, Optiray 300, Optiray 320, Optiray 350)?

Some of the side effects of ioversol can occur up to 24 hours after you have received the medication.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

urinating less than usual or not at all;
severe muscle pain or weakness;
...
Read All Potential Side Effects for Optiray Injection »




OPTIRAY (ioversol injection) formulations are sterile, nonpyrogenic, aqueous
solutions intended for intravascular administration as diagnostic radiopaque
media. Ioversol is designated chemically as N,N'-Bis (2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)
-glycolamido] -2,4,6-triiodoisophthalamide and has the following structural
formula:








The molecular weight of ioversol is 807.11 and the organically bound iodine content is 47.2%. Ioversol is nonionic and does not dissociate in solution.
Each milliliter of OPTIRAY 350 (ioversol injection 74%) contains 741 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 350 provides 35% (350 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 320 (ioversol injection 68%) contains 678 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 320 provides 32% (320 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 300 (ioversol injection 64%) contains 636 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 300 provides 30% (300 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 240 (ioversol injection 51%) contains 509 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 240 provides 24% (240 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 160 (ioversol injection 34%) contains 339 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 160 provides 16% (160 mg/mL) organically bound iodine.
The pH of the OPTIRAY formulations has been adjusted to 6.0 to 7.4 with hydrochloric acid or sodium hydroxide. All solutions are sterilized by autoclaving and contain no preservatives. Unused portions should be discarded. OPTIRAY solutions are sensitive to light and therefore should be protected from exposure.
Some physical and chemical properties of these formulations are listed below:



 
OPTIRAY
160
OPTIRAY
240
OPTIRAY
300
OPTIRAY
320
OPTIRAY
350


Ioversol content (mg/mL)
339
509
636
678
741


Iodine content (mg I/mL)
160
240
300
320
350


Osmolality (mOsm/kg water)
355
502
651
702
792


Viscosity (cps)


at 25°C
2.7
4.6
8.2
9.9
14.3


at 37°C
1.9
3.0
5.5
5.8
9.0


Specific Gravity at 37°C
1.188
1.281
1.352
1.371
1.405



The OPTIRAY formulations are clear, colorless to pale yellow solutions containing
no undissolved solids. Crystallization does not occur at room temperature. The
products are supplied in containers from which the air has been displaced by
nitrogen. OPTIRAY solutions have osmolalities 1.2 to 2.8 times that of plasma
(285 mOsm/kg water) as shown in the above table and are hypertonic under conditions
of use.Last reviewed on RxList: 6/18/2008




Optiray Injection Drug Description
Optiray™ 350
(ioversol) Injection 74%
Optiray™ 320
(ioversol) Injection 68%
Optiray™ 300
(ioversol) Injection 64%
Optiray™ 240
(ioversol) Injection 51%
Optiray™ 160
(ioversol) Injection 34%

WARNING
NOT FOR INTRATHECAL USE

DRUG DESCRIPTION



What are the possible side effects of ioversol (Optiray 160, Optiray 240, Optiray 300, Optiray 320, Optiray 350)?

Some of the side effects of ioversol can occur up to 24 hours after you have received the medication.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

urinating less than usual or not at all;
severe muscle pain or weakness;
...
Read All Potential Side Effects for Optiray Injection »




OPTIRAY (ioversol injection) formulations are sterile, nonpyrogenic, aqueous
solutions intended for intravascular administration as diagnostic radiopaque
media. Ioversol is designated chemically as N,N'-Bis (2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)
-glycolamido] -2,4,6-triiodoisophthalamide and has the following structural
formula:








The molecular weight of ioversol is 807.11 and the organically bound iodine content is 47.2%. Ioversol is nonionic and does not dissociate in solution.
Each milliliter of OPTIRAY 350 (ioversol injection 74%) contains 741 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 350 provides 35% (350 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 320 (ioversol injection 68%) contains 678 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 320 provides 32% (320 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 300 (ioversol injection 64%) contains 636 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 300 provides 30% (300 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 240 (ioversol injection 51%) contains 509 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 240 provides 24% (240 mg/mL) organically bound iodine.
Each milliliter of OPTIRAY 160 (ioversol injection 34%) contains 339 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg of edetate calcium disodium as a stabilizer. OPTIRAY 160 provides 16% (160 mg/mL) organically bound iodine.
The pH of the OPTIRAY formulations has been adjusted to 6.0 to 7.4 with hydrochloric acid or sodium hydroxide. All solutions are sterilized by autoclaving and contain no preservatives. Unused portions should be discarded. OPTIRAY solutions are sensitive to light and therefore should be protected from exposure.
Some physical and chemical properties of these formulations are listed below:



 
OPTIRAY
160
OPTIRAY
240
OPTIRAY
300
OPTIRAY
320
OPTIRAY
350


Ioversol content (mg/mL)
339
509
636
678
741


Iodine content (mg I/mL)
160
240
300
320
350


Osmolality (mOsm/kg water)
355
502
651
702
792


Viscosity (cps)


at 25°C
2.7
4.6
8.2
9.9
14.3


at 37°C
1.9
3.0
5.5
5.8
9.0


Specific Gravity at 37°C
1.188
1.281
1.352
1.371
1.405



The OPTIRAY formulations are clear, colorless to pale yellow solutions containing
no undissolved solids. Crystallization does not occur at room temperature. The
products are supplied in containers from which the air has been displaced by
nitrogen. OPTIRAY solutions have osmolalities 1.2 to 2.8 times that of plasma
(285 mOsm/kg water) as shown in the above table and are hypertonic under conditions
of use.Last reviewed on RxList: 6/18/2008





Other reviews about Optiray Injection on wordpress

my cat scan 2
  by jeanne
i never thought, when i first got cancer, that i would become so familiar with the route to the hospitals, the corridors of the hospitals, the tunnels and […]


58:9 Then shalt thou c
  by cxrgexgttbkquld
Stu and Fran werent the only ones with a touch of the wanderlust, apparently. Come, you must tell me all about it while I get that drink for […]



Other reviews about Optiray Injection on web:

Learn about the prescription medication Optiray Injection (Ioversol Injection), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Optiray Injection (Ioversol Injection) Drug Information: Uses ...


Learn about Optiray Injection (Ioversol Injection) - Side Effects, Drug Interactions, Pictures, Patient Information on RxList Optiray Injection (Ioversol Injection) Patient Drug Information ...


Patients should be well hydrated prior to and following Optiray (ioversol injection) administration. As with all contrast media, other drugs should not be mixed with ioversol ... Optiray Official FDA information, side effects and uses.


As Optiray is administered on a need-only basis before the X-ray scan, in hospital settings and as the injection is performed by an authorized health care professional, it is ... Buy Optiray (Ioversol) Online Now


Optiray™ 320 (ioversol injection)–– part of today’s only fully integrated contrast media delivery system that helps improve efficiency for CT imaging. Optiray™ 320


Information architecture, Web Design, Web Standards. ... ...Optiray™ 350Ioversol Injection 74%, 350 mg/mL organically bound iodine WARNING - NOT FOR INTRATHECAL USE Optiray ... ADVANCE MEDICAL TECHNOLOGY


Following coronary artery and left ventricular injection, electrocardiographic parameters were affected less with Optiray (ioversol injection) than with diatrizoate meglumine and ... Optiray Side Effects | Drugs.com


optiray (Ioversol) injection [Mallinckrodt Inc.] tyco Healthcare/Mallinckrodt Inc. Rx only. Pharmacy Bulk Package - Not for Direct Infusion. WARNING Optiray™ Pharmacy Bulk Package – 350[IOVERSOL INJECTION 74% ...


Find out all about optiray injection side effects, including the most common uses, side effects, interactions and risk factors from leading medical experts. Optiray Injection Side Effects - a comprehensive view - Wellsphere


They told me I could mix Crystal Lite in it to make it taste better. I've been looking online but can't find anywhere that they mention Optiray 300 except via injection. Optiray News





Featured Reviews

Reviews Succimer

Chemet Drug Description CHEMET® (succimer) Capsule 100 mg DRUG DESCRIPTION What are the possible side effects of succimer (Chemet)? Seek emergency medical attention or contact your doctor immediately if you experience any of...
Read More  |  Review This
Reviews Alcaine

Alcaine Drug Description ALCAINE® (proparacaine hydrochloride 0.5%) Sterile Ophthalmic Solution USE THIS PRODUCT ONLY ON THE ADVICE OF A PHYSICIAN DRUG DESCRIPTION ALCAINE® (Proparacaine Hydrochloride) is a topical anesthetic...
Read More  |  Review This
Reviews Ethinyl Estradiol and Ethynodiol Diacetate

Demulen Drug Description DRUG DESCRIPTION The chemical name for ethyndiol diacetate is 19-nor-17alpha-pregn-4-en-20-yne-3beta,17-diol diacetate, and for ethinyl estradiol it is 19-nor- 17alpha-pregna-1,3,5 (10)-trien-20-yne-3,17-diol....
Read More  |  Review This
Reviews Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine

Tripedia Drug Description Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Tripedia® DRUG DESCRIPTION What are the possible side effects of diphtheria, tetanus, and pertussis vaccines (Acel-Imune, Certiva,...
Read More  |  Review This
Reviews Conivaptan Hcl Injection

Vaprisol Drug Description VAPRISOL® (conivaptan hydrochloride) Injection, for Intravenous Use DRUG DESCRIPTION What are the possible side effects of conivaptan (Vaprisol)? Tell your doctor or nurse right away if you have any...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....